Correspondence to “The effectiveness of pollen allergen immunotherapy on allergic rhinitis over 18 years: A national cohort study in Denmark”
Allergy, EarlyView.
Mon May 6, 2024 10:38
Four years into the COVID‐19 pandemic: Timely published articles for patient care and EAACI's leadership role
Allergy, EarlyView.
Sat May 4, 2024 12:18
Digitally‐enabled, person‐centred care (PCC) in allergen immunotherapy: An ARIA‐EAACI Position Paper
Abstract In rhinitis and asthma, several mHealth apps have been developed but only a few have been validated. However, these apps have a high potential for improving person-centred care (PCC), especially in allergen immunotherapy (AIT). They can provide support in AIT initiation by selecting the appropriate patient and allergen shared decision-making....
Sat May 4, 2024 12:18
Efficacy and safety of a 7‐week immunotherapy protocol with aluminium hydroxide adsorbed hymenoptera venom
Allergy, EarlyView.
Sat May 4, 2024 12:18